CRIS Current Research Information System

COCCO, LUCIO ILDEBRANDO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 17.640
AS - Asia 13.592
EU - Europa 12.499
AF - Africa 1.127
SA - Sud America 845
OC - Oceania 37
Continente sconosciuto - Info sul continente non disponibili 20
Totale 45.760
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 17.426
SG - Singapore 4.054
CN - Cina 3.371
VN - Vietnam 3.207
GB - Regno Unito 2.824
IT - Italia 2.610
DE - Germania 1.791
SE - Svezia 1.512
HK - Hong Kong 924
FR - Francia 761
IN - India 658
RU - Federazione Russa 629
BR - Brasile 578
UA - Ucraina 520
IE - Irlanda 403
JP - Giappone 305
ZA - Sudafrica 285
TG - Togo 279
NL - Olanda 268
KR - Corea 218
FI - Finlandia 214
EE - Estonia 212
SC - Seychelles 194
BD - Bangladesh 169
CI - Costa d'Avorio 169
CA - Canada 130
AR - Argentina 121
CH - Svizzera 121
BG - Bulgaria 106
AT - Austria 105
HR - Croazia 103
NG - Nigeria 102
BE - Belgio 88
JO - Giordania 87
ID - Indonesia 79
PH - Filippine 71
TH - Thailandia 64
TR - Turchia 58
PK - Pakistan 56
PL - Polonia 46
MX - Messico 43
GR - Grecia 41
EC - Ecuador 40
IQ - Iraq 38
ES - Italia 34
TW - Taiwan 31
SA - Arabia Saudita 29
UZ - Uzbekistan 29
AU - Australia 26
MY - Malesia 26
CO - Colombia 25
RO - Romania 23
IR - Iran 20
CL - Cile 19
EG - Egitto 19
PY - Paraguay 18
EU - Europa 15
VE - Venezuela 15
IL - Israele 14
LB - Libano 14
TN - Tunisia 14
JM - Giamaica 13
PE - Perù 13
AE - Emirati Arabi Uniti 12
ET - Etiopia 12
LT - Lituania 12
MA - Marocco 12
PT - Portogallo 12
NP - Nepal 11
UY - Uruguay 11
HU - Ungheria 10
DZ - Algeria 9
KE - Kenya 9
NZ - Nuova Zelanda 9
CZ - Repubblica Ceca 8
DK - Danimarca 8
MD - Moldavia 8
OM - Oman 7
AL - Albania 5
AZ - Azerbaigian 5
DO - Repubblica Dominicana 5
LV - Lettonia 5
QA - Qatar 5
SN - Senegal 5
BO - Bolivia 4
GT - Guatemala 4
KZ - Kazakistan 4
LU - Lussemburgo 4
SI - Slovenia 4
SY - Repubblica araba siriana 4
AO - Angola 3
BW - Botswana 3
CR - Costa Rica 3
KG - Kirghizistan 3
MN - Mongolia 3
RS - Serbia 3
SK - Slovacchia (Repubblica Slovacca) 3
SV - El Salvador 3
TT - Trinidad e Tobago 3
A2 - ???statistics.table.value.countryCode.A2??? 2
Totale 45.710
Salva come PNG Salva come JPEG
Città #
Singapore 2.777
Southend 2.447
Ashburn 1.785
Fairfield 1.674
Chandler 1.237
Santa Clara 1.003
San Jose 912
Hong Kong 876
Houston 812
Woodbridge 788
Bologna 783
Wilmington 720
Ann Arbor 700
Seattle 671
Ho Chi Minh City 648
Cambridge 586
Princeton 586
Hanoi 521
Beijing 493
Dong Ket 487
Boardman 445
Dublin 401
Hefei 304
Jacksonville 296
Lomé 279
Lauterbourg 275
Nanjing 267
Westminster 259
Padova 251
Dallas 225
Tokyo 225
Los Angeles 205
New York 197
Frankfurt am Main 193
Berlin 182
Helsinki 171
Abidjan 169
Milan 169
Buffalo 163
Council Bluffs 148
Jinan 135
Saint Petersburg 135
San Diego 124
Shenyang 116
Sofia 105
Da Nang 104
Changsha 102
Seoul 100
Abeokuta 98
Nanchang 90
Redondo Beach 89
Bern 88
Florence 86
Guangzhou 86
Amman 84
Haiphong 82
Brussels 79
Munich 78
Redwood City 77
Hebei 73
Turin 73
Medford 70
Rome 69
Shanghai 69
Vienna 69
São Paulo 67
Chicago 66
Orem 63
Mülheim 62
Johannesburg 57
London 56
Bremen 53
Zhengzhou 48
Des Moines 47
Falls Church 46
Tianjin 46
Norwalk 45
San Francisco 45
Redmond 44
Dearborn 42
Nuremberg 42
Amsterdam 40
Hangzhou 40
Jakarta 40
Haikou 39
Jiaxing 38
Toronto 38
Montreal 35
Phoenix 35
Yubileyny 35
Atlanta 33
Kunming 33
Verona 33
Falkenstein 32
Mahé 32
Warsaw 32
Bangkok 31
Moscow 31
Ningbo 31
Parma 31
Totale 29.099
Salva come PNG Salva come JPEG
Nome #
Multiple roles of phosphoinositide-specific phospholipase C isozymes. 426
Cell signaling pathways in autosomal-dominant leukodystrophy (ADLD): the intriguing role of the astrocytes 354
Effects of resveratrol, curcumin, berberine and other nutraceuticals on aging, cancer development, cancer stem cells and microRNAs 296
Clinical and molecular insights in erythropoiesis regulation of signal transduction pathways in myelodysplastic syndromes and β-thalassemia 291
Near-peer teaching in human anatomy from a tutors’ perspective: An eighteen-year-old experience at the university of Bologna 291
Ankrd2/ARPP is a novel Akt2 specific substrate and regulates myogenic differentiation upon cellular exposure to H(2)O(2 290
Clinical Impact of Hypomethylating Agents in the Treatment of Myelodysplastic Syndromes 282
Activation of nuclear inositide signalling pathways during erythropoietin therapy in low-risk MDS patients 272
A miRNA screening identifies miR-192-5p as associated with response to azacitidine and lenalidomide therapy in myelodysplastic syndromes 263
ALIVE CEROPLASTICS 4D Representations 259
Impact of phospholipase C β1 in glioblastoma: a study on the main mechanisms of tumor aggressiveness 255
Prolonged low-dose azacitidine schedule in high-risk MDS patients: Hematologic and molecular response 254
Inositide-Dependent Nuclear Signalling in Health and Disease 251
Endoscopic endonasal anatomy of the ophthalmic artery in the optic canal 245
Cancer therapy and treatments during COVID-19 era 243
A role for PKCepsilon during C2C12 myogenic differentiation 241
Regulation of GSK-3 activity by curcumin, berberine and resveratrol: Potential effects on multiple diseases 239
Strategic Role of Nuclear Inositide Signalling in Myelodysplastic Syndromes Therapy 233
Abilities of berberine and chemically modified berberines to inhibit proliferation of pancreatic cancer cells. 231
AZACITIDINE IN MYELODYSPLASTIC SYNDROMES: RETROSPECTIVE EVALUATION OF LONG-RESPONDER PATIENTS 228
Molecular Characterization of High-Risk MDS Patients Treated with Azacitidine and Lenalidomide: Role of Inositide-Dependent Signalling, Mutations and Microrna 228
Clonal Effect Of Lenalidomide On Akt Activation In Low-Risk MDS Patients With Del(5q) 227
Response of high-risk MDS to azacitidine and lenalidomide is impacted by baseline and acquired mutations in a cluster of three inositide-specific genes 227
Activated human NK and CD8+ T cells express both TNF-related apoptosis-inducing ligand (TRAIL) and TRAIL receptors but are resistant to TRAIL-mediated cytotoxicity. 225
Clonal activation of Akt in low-risk MDS patients with del(5q) treated with lenalidomide 225
BMP-2 Induced Expression of PLCβ1 That is a Positive Regulator of Osteoblast Differentiation 225
Nuclear Inositides and Inositide-Dependent Signaling Pathways in Myelodysplastic Syndromes 225
Catalytic activity of nuclear PLC-beta(1) is required for its signalling function during C2C12 differentiation. 222
AZACITIDINE FOR HIGH RISK MYELODYSPLASTIC SYNDROMES. RETROSPECTIVE EVALUATION OF TWO DIFFERENT DOSING SCHEDULES 219
AZACITIDINE IN HIGH AND LOW RISK MYELODYSPLASTIC SYNDROMES: RETROSPECTIVE EVALUATION OF 57 PATIENTS TREATED WITH 4 DIFFERENT THERAPEUTIC REGIMENS 217
An increased expression of PI-PLCβ1 is associated with myeloid differentiation and a longer response to azacitidine in myelodysplastic syndromes 215
AKT-dependent phosphorylation of the adenosine deaminases ADAR-1 and -2 inhibits deaminase activity 214
Communication between median and musculocutaneous nerve at the level of cubital fossa - A case report 214
Nuclear inositide signaling and cell cycle 213
Role of PLCγ1 in the modulation of cell migration and cell invasion in glioblastoma 213
PLC-β1 and cell differentiation: An insight into myogenesis and osteogenesis 210
Abilities of β-Estradiol to interact with chemotherapeutic drugs, signal transduction inhibitors and nutraceuticals and alter the proliferation of pancreatic cancer cells 210
Prospective phase II Study on 5-days azacitidine for treatment of symptomatic and/or erythropoietin unresponsive patients with low/INT-1-risk myelodysplastic syndromes 208
Azacitidine in Myelodysplastic Syndromes: Multicenter Retrospective Study of 34 Long-Responder Patients 207
Nuclear phospholipase C isoenzyme imbalance leads to pathologies in brain, hematologic, neuromuscular, and fertility disorders 207
Nuclear Inositide Signaling via Phospholipase C 206
Lamin B1 accumulation’s effects on autosomal dominant leukodystrophy (ADLD): Induction of reactivity in the astrocytes 205
Endoscopic endonasal approach to primitive Meckel's cave tumors: a clinical series 204
Modulating Phosphoinositide Profiles as a Roadmap for Treatment in Acute Myeloid Leukemia 204
Early Increase of Phospholipase Cbeta1 (PI-PLCbeta1) Gene Expression Predicts Azacitidine Responsiveness in MDS Patients 202
Nuclear Localization of Diacylglycerol Kinase Alpha in K562 Cells Is Involved in Cell Cycle Progression 202
Location-dependent role of phospholipase C signaling in the brain: Physiology and pathology 202
Nuclear phospholipase C β1 signaling, epigenetics and treatments in MDS 201
The wide and growing range of lamin B‑related diseases: from laminopathies to cancer 199
Aberrant expression of B203.13 antigen in acute lymphoid leukemia of B-cell origin. 198
Intranuclear 3'-phosphoinositide metabolism and Akt signaling: New mechanisms for tumorigenesis and protection against apoptosis? 196
Revisiting nuclear phospholipase C signalling in MDS 195
Nuclear inositide specific phospholipase C signalling - interactions and activity 195
Nuclear inositides: facts and perspectives. 194
IPMK and β-catenin mediate PLC-β1-dependent signaling in myogenic differentiation 194
Signaling pathways and bone marrow microenvironment in myelodysplastic neoplasms 193
Toxicity of antimony trioxide nanoparticles on human hematopoietic progenitor cells and comparison to cell lines. 192
Anatomical variations of the right renal and spermatic arteries: a case report 191
Inositide signaling: Nuclear targets and involvement in myelodysplastic syndromes 188
Phospholipase C beta1 (PI-PLCbeta1)/Cyclin D3/protein kinase C (PKC) alpha signaling modulation during iron-induced oxidative stress in myelodysplastic syndromes (MDS) 188
Epigenetic regulation of nuclear inositide signalling in high-risk MDS patients 187
Phosphoinositide-dependent signaling in cancer: A focus on phospholipase C isozymes 187
Subcellular localization relevance and cancer-associated mechanisms of diacylglycerol kinases 186
Inositide signaling in the nucleus: From physiology to pathology. 185
Nuclear diacylglycerol kinase-theta is activated in response to nerve growth factor stimulations of PC12 cells 184
Frequent Elevation of Akt Kinase Phosphorylation in Blood Marrow and Peripheral Blood Mononuclear Cells from High Risk myelodysplastic Syndrome Patients 184
Real-time PCR as a tool for quantitative analysis of PI-PLCbeta1 gene expression in myelodysplastic syndrome. 184
Unilateral absence of Casserio’s nerve and a communicating branch to the median nerve. An additional variant of brachial flexors motor innervation 184
Phospholipase C-β1 interacts with cyclin E in adipose- derived stem cells osteogenic differentiation 184
Advances in MDS/AML and inositide signalling 183
Regulation of nuclear phospholipase C activity 183
Multiple forms of PKR present in the nuclei of acute leukemia cells represent an active kinase that is responsive to stress 183
Therapeutic potential of nvp-bkm120 in human osteosarcomas cells 183
Physiology and pathology of nuclear phospholipase C beta1 182
Anticancer agents sensitize osteosarcoma cells to TNF-related apoptosis-inducing ligand downmodulating IAP family proteins. 180
Signaling Role of Pericytes in Vascular Health and Tissue Homeostasis 179
eEF1A phosphorylation in the nucleus of insulin-stimulated C2C12 myoblasts: Ser53 is a novel substrate for protein kinase C βI 179
A role for PLCbeta1 in myotonic dystrophies type 1 and 2. 179
Expression of signal transductions proteins during the differentiation of primary human erythroblasts 178
Demethylation and Up-Regulation of an Oncogene after Hypomethylating Therapy 178
Application of flow cytometry to molecular medicine: Detection of tumor necrosis factor-related apoptosis-inducing ligand receptors in acute myeloid leukaemia blasts 177
Inositide-specific phospholipase c beta1 gene deletion in the progression of myelodysplastic syndrome to acute myeloid leukemia 176
Nuclear phospholipase C beta1 and cellular differentiation. 175
Nuclear PI-PLCβ1 and Myelodysplastic Syndromes: Genetics and Epigenetics 175
Effect of Lenalidomide Treatment on Lipid Signalling Pathways in Low-Risk MDS Patients 175
Effects of TP53 Mutations and miRs on Immune Responses in the Tumor Microenvironment Important in Pancreatic Cancer Progression 174
Inositide-dependent signaling pathways as new therapeutic targets in myelodysplastic syndromes 174
Advances in Enzyme Regulation 173
Advances in Targeting Signal Transduction Pathways. 173
A role for PKR in hematologic malignancies 173
Signal transduction within the nucleus: Revisiting phosphoinositide inositide-specific phospholipase Cbeta(1). 171
Protein kinase C involvement in cell cycle modulation 171
Nuclear inositol lipid metabolism: more than just second messenger generation? 171
Nuclear Phosphatidylinositol Signaling: Focus on Phosphatidylinositol Phosphate Kinases and Phospholipases C 171
Hypo and retrotympanum: the importance of anatomical variants 171
Expression of phosphoinositide-specific phospholipase C isoenzymes in cultured astrocytes 170
The Akt/mammalian target of rapamycin signal transduction pathway is activated in high-risk myelodysplastic syndromes and influences cell survival and proliferation 170
Expression of phospholipase C beta family isoenzymes in C2C12 myoblasts during terminal differentiation. 170
A role of PI-PLCb1 in G1/S transition in human erythroleukemia k562 cells 169
Phosphoinositide 3-kinase/Akt involvement in arsenic trioxide resistance of human leukemia cells 169
Totale 20.844
Salva come PNG Salva come JPEG
Categoria #
all - tutte 131.442
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 131.442
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.121 0 0 0 0 0 0 0 0 0 0 0 1.121
2021/20225.558 549 132 354 471 461 313 159 360 178 773 923 885
2022/20235.724 597 742 327 780 459 427 288 339 897 121 411 336
2023/20241.916 109 302 180 188 221 330 95 69 91 134 76 121
2024/20256.229 215 949 615 353 1.309 337 453 232 105 303 200 1.158
2025/202613.944 959 1.337 1.394 927 1.735 940 1.634 498 2.473 968 635 444
Totale 46.648